Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. - Wikidata - wikimedia - TriplyDB

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

http://www.wikidata.org/entity/Q35234767

about

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox The Future of Smallpox Vaccination: is MVA the key?The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agents Using the TAP component of the antigen-processing machinery as a molecular adjuvant Cytokine production associated with smallpox vaccine responses Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox Wanted, dead or alive: New viral vaccines Viral Vaccines and CTL Response Poxvirus tropism Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.The poxvirus A35 protein is an immunoregulator Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.T cell inactivation by poxviral B22 family proteins increases viral virulence.Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice The immunology of smallpox vaccines.Gender effects on humoral immune responses to smallpox vaccine.Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection.Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes.Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections.Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin

P2860

Q24623839-C6D2B20E-6BC9-4E37-873D-CCF0B2ADE5AF Q24801195-9AE552CD-70C0-4528-8C3C-3F759C7F074B Q24804488-BEA88D73-7C4A-4BA9-BB6A-2EBAFF900D63 Q25256237-3D2849E9-4AF9-482E-A98C-BCCD70E90C61 Q26823501-CF8F20F3-0D14-4A94-9250-0474F3D22F61 Q27346800-73376D5C-643C-4B03-B646-94C7DC0149B1 Q27346933-56DAFC3F-257F-4156-9F92-2A08AB34C228 Q27489979-31CF6AEB-6FD6-46A6-8F90-4A22BB2480EC Q27491330-C3B38E6F-D105-482D-A00B-82E079A4E682 Q28237434-23BAD218-9620-4578-B880-0BBB295DF622 Q28384852-45DBCC38-B096-49EF-8F84-C587F59B4A0B Q28476707-7066FF75-A0DE-4F06-9A2E-08B2DD92B1F7 Q30449492-71DADFF1-4B06-4BF0-ACD7-EC4C89280CE5 Q30973875-40244542-BEF3-4F3A-A9A4-08611F45A6F4 Q33210436-516DAEC6-1514-4C58-8C59-A99A075F6177 Q33328336-FB911E14-EA55-42CA-B13E-3E21BEE6B9AD Q33558734-2A82DB11-D7D8-48B3-854C-67A53955AF4E Q33602820-0FEF5F05-7EB6-4B1A-96D9-44FC96D8E298 Q33618867-8B5C7FBE-6268-460B-BE44-FF372F387448 Q33625383-990FF0CB-67CA-4DF0-ABF5-6272B71B25C9 Q33639966-E4E89CA3-0FDA-4204-A081-BECA6C084E83 Q33679943-C89F950D-7A32-4607-94C0-E4D58DA5CFAF Q33701473-80C04E13-2379-46AF-A04B-FC7DF06CDF36 Q33725635-808D025C-133B-4EA3-A1C7-B51DFE202D2B Q33780579-BDDE9B33-6462-41A8-AE60-77B709121BFE Q33883711-61E31402-25B6-4AB9-A119-3E19F0992019 Q33936717-768EA8BC-18C7-49C3-8571-9D0D001F4CE3 Q33972574-71E03FFA-9B02-4568-9D88-19B5C4E78557 Q33987410-7AB867EA-CD43-4460-B6D4-DC759C9E518E Q33987538-A428EC2D-5674-4B2F-8346-CAE1533E2AD8 Q34048199-02E81197-80B1-4DF9-8CEA-0E3783094017 Q34092845-009354B4-16F0-467B-9217-54A916AB2157 Q34120696-8798FD50-6432-4307-86D8-1971A906067C Q34171543-88227043-BFB3-495F-8092-FAFE007C5128 Q34182371-1C611CF1-B005-4027-82AE-6E441D493827 Q34260856-A3AB6864-529B-405B-BB5E-B1F3863FC55B Q34414790-EBDF3D4C-F5CE-4622-AFD3-D9B859B7BDB7 Q34428899-AFE1969D-2E46-4391-A530-1AE74425BDF0 Q34447009-3E877D32-481B-4DA8-9F6C-D94A0F7B46A3 Q34484027-3D362FFC-2B99-4414-A054-15796898A1F8

P2860

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.

http://www.wikidata.org/entity/Q35234767

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@ast

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@en

type

label

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@ast

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@en

prefLabel

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@ast

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@en

P1433

Q35234767-D078F891-26A5-42E7-B5BD-4BCF72205EFD

P1476

Q35234767-E0F12C33-944A-4FBA-BE48-3A2A200BED1C

P2093

Q35234767-1B799F74-166B-4FCD-8959-AFD7C57B492B

Q35234767-25E25F6D-BC5F-4A8E-9363-F3314170D871

Q35234767-28F15D04-B4CD-4EA0-A03F-D079BA8E98DE

Q35234767-2B74BA2B-F9E8-452A-A289-A60D9E6754FE

Q35234767-31A7C479-DAB6-48B4-9740-8E1A80378B50

Q35234767-5063ADB2-3DD6-4333-9EF5-DD65F441292F

Q35234767-61744298-BDA1-45EC-9B64-6CD58CC64083

Q35234767-8A5E565C-84DD-4CE6-B246-7B1D54A0BBA6

Q35234767-A5287A17-5C31-4B23-9298-3726EC3AB09B

Q35234767-C6A7F9E8-EAD1-4368-894E-1D64B2876981

P2860

Q35234767-0C032DB2-8A1F-453D-9AB9-2758095675A8

Q35234767-0EB61244-D7B6-48D0-94E1-55044BB08DEE

Q35234767-17917E07-1F73-49EB-B0CB-185481C034E2

Q35234767-17D226F9-7554-4251-BBBF-9FE0EF46F1CE

Q35234767-1905DC94-02DA-4AAC-B1D6-7763E853C191

Q35234767-2696FD81-C423-4CA6-9E40-6CE3F5DC1AB0

Q35234767-2ABA2D78-AF95-4DAA-9E68-3D11DFB822B7

Q35234767-335C2D66-E322-4513-B913-88E60723C7B3

Q35234767-3FC6A20D-2D58-4BE2-9CD8-78805E1B8797

Q35234767-423EED39-2698-4D5A-81E7-C4C9E707B086

P304

Q35234767-48414278-5D5C-48AB-925C-241FBCACBD1E

P31

Q35234767-EBB61E43-9918-40F7-A222-CFB77F536910

P356

Q35234767-B32663CD-B7C3-4E34-ADAA-8C22E7279B6E

P407

Q35234767-1ABC7D50-741A-40D1-B4EE-AB740451F3B4

P433

Q35234767-AA269AC0-8343-4CA6-B2BE-4751CF5185BA

P478

Q35234767-F06E9521-B117-451C-BF60-DDA7DD7A0F4E

P50

Q35234767-8B5EB2FA-D49B-4AA2-AF64-954204F7739F

P577

Q35234767-6AF1EC76-86E9-4253-9DC8-125F99D54E97

P5875

Q35234767-0F9F4F6E-82B0-459A-8C2E-AED9AEBE42A7

P698

Q35234767-D533B36F-A6AD-443A-9576-98160CC8900C

P921

Q35234767-872BC8AA-C6EE-4B37-8781-9773C1BE57CB

Q35234767-DDFC51EA-28F4-4F81-BAED-AD9F58DAE4CB

P932

Q35234767-A9871137-F677-4ED5-9C32-11DCE7EAA775

P356

PNAS.1233578100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Shared modes of protection aga ...... onal smallpox vaccine viruses.

@en

P2093

Amiran Dzutsev

http://www.w3.org/2001/XMLSchema#string

Genoveffa Franchini

http://www.w3.org/2001/XMLSchema#string

Igor M Belyakov

http://www.w3.org/2001/XMLSchema#string

James T Snyder

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Ahlers

http://www.w3.org/2001/XMLSchema#string

Linda S Wyatt

http://www.w3.org/2001/XMLSchema#string

Michael Lemon

http://www.w3.org/2001/XMLSchema#string

Patricia Earl

http://www.w3.org/2001/XMLSchema#string

Vladimir A Kuznetsov

http://www.w3.org/2001/XMLSchema#string

P2860

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo

Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Strategies for designing and optimizing new generation vaccines.

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.

Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

P304

9458-9463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1233578100

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10654207

http://www.w3.org/2001/XMLSchema#string

P698

12869693

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

170940

http://www.w3.org/2001/XMLSchema#string